Transparency Market Research
Biochips Market
Single User License:
USD 4315.5
 Flat 10% Discount!!
 Free Customization as per your requirement
 You will get Custom Report at Syndicated
Report price
 Report will be delivered with in 15-20
working days
Request Sample
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
[email protected]
Download Brochure
The development of biochips has been able to influence the growth of automated processes and miniaturization of
products throughout all major sectors covered in report. In the healthcare sector, biochips are largely used in
laboratories for drug discovery and research for symptoms of diseases. The laboratory equipments have become
smaller and efficient due to the use of biochips. In addition, biochips are capable of performing multiple biochemical
reactions simultaneously and easily. Moreover, it helps in identifying and detecting gene sequences and analyzing
proteins in animal and human bodies. Biochips are largely used in in-vitro diagnostics, where it detects symptoms of
diseases and provides cure for the same. It is also capable of carrying out tests for analyzing pandemics, drug tests,
glucose monitoring, diabetic control and diagnosis of various diseases. In addition, biochips ensure accurate and
precise modelling physiological situations for both drug development and fundamental research. Moreover, it helps
in carrying out high volume tests for numerous aspects in drug discovery and development. In the dynamic business
environment where numerous technological advancements are taking place each day, it is necessary for the
biochips manufacturing companies to align its strategies with the technological shifts in order to achieve a
sustainable growth and profitable returns. Moreover, the use of biochips has revolutionized molecular diagnostics in
identifying the presence of organisms such as bacteria and virus in patient samples, detecting genetic disorders and
monitoring of viral responses to therapy. Home monitoring biochip systems are expected to detect and provide
healthcare solutions with the help of computers to patients in their homes. For initial advice regarding treatment,
biochip-enabled computer systems would be able to transmit to the hospital using wireless telemetry, thereby
providing the individual with a suitable cure without any delay and effort.
Full Report Description of Biochips Market is available at:
However, there are a few factors, which are inhibiting the growth of biochips market globally. Companies that
manufacture biochips have to comply with a number of regulations relating to medical devices such as Clinical and
Laboratory Standards Institute (CLSI) and United States Pharmacopeia (USP) among others, which poses a major
challenge for a large number of companies. Microarrays, which are a two-dimensional grid of biosensors, are the
essential components of biochips. The sensors are placed on a solid substrate that may be active or passive. Passive
substrates are either silicon or glass, which are largely used because silicon and glass have well-established micro
fabrication and micromachining processes. Passive substrates require silica etching, which is a time consuming
process and entails the use of special resources and a large amount of chemical solvents that pose a threat to
environmental safety. The environmental hazards related to the use of glass and silicon as popular substrates for
biochips are expected to inhibit the global biochips market significantly.
The biochips market has huge scope and opportunity in the emerging markets of Asia Pacific and Rest of the World
(RoW). Countries such as India, China, Japan, and Australia are the key biochips markets falling under the Asia Pacific
and RoW regions. Biochips are increasingly finding application in the biotechnology and biomedical devices
industries. Molecular diagnostics and drug discovery are the major driving factors influencing the growth of the
industries. Moreover, venture capital firms globally are investing heavily in biochip technology.
In North America, the U.S. has been showing significant growth over the years and is one of the dominant biochips
markets globally. Japan, China and India are the largest contributors to the biochips market in the Asia Pacific region.
In Europe, Germany and U.K. are the largest regional markets for biochips because of increasing investments in
biochips technology and growth in the healthcare sector. Latin America and UAE are showing substantial growth and
are expected to be key markets in the coming years.
Key participants in the industry include Affymetrix Inc. (U.S.), Illumina Inc. (U.S.), GE Healthcare Ltd. (U.K.), Cepheid
Inc. (U.S.), Fluidigm Corporation (U.S.) and Agilent Technologies Inc. (U.S.) among others.
Download the Brochure of this Market Report at:
About TMR
Transparency Market Research (TMR) is a global market intelligence company, providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts,
Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather
and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always
reflects the latest trends and information. With a broad research and analysis capability, Transparency
Market Research employs rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact TMR
Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Biochips are a collection of microarrays which are arranged on a solid substrate that enables numerous biochemical reactions such as decoding of genes in a few seconds. Increasing application of biochips in the medical sector for cancer treatment, drug research, and diagnostics is one of the major factors driving the growth of the global biochips market.